• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后CA19-9正常化对晚期胃癌患者的预后价值

Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer.

作者信息

Kwon Oh Kyoung, Yu Wansik, Chung Hoyoung

机构信息

Gastric Cancer Center, Kyungpook National University Medical Center, Daegu, Korea.

出版信息

Hepatogastroenterology. 2013 Mar-Apr;60(122):240-3. doi: 10.5754/hge12585.

DOI:10.5754/hge12585
PMID:22975648
Abstract

BACKGROUND/AIMS: CA19-9 is known to have positive correlation with depth of invasion, nodal involvement, and peritoneal metastasis in gastric adenocarcinoma. In patients with high preoperative CA19-9 serum levels who underwent curative gastrectomy, we evaluated the prognostic impact of postoperative normalization of CA 19-9.

METHODOLOGY

Among 1,439 patients who underwent curative gastrectomy for advanced gastric adenocarcinoma, data of 102 patients with advanced gastric adenocarcinoma whose preoperative serum CA19-9 level was higher than cutoff value (37 U/mL) were reviewed. If serum CA19-9 level had fallen below 37 U/mL at 6 months after surgery, the CA19-9 level was considered normalized.

RESULTS

CA19-9 levels were normalized in 79 patients but not in 23 patients. There were statistically significant differences in prognosis according to depth of invasion, presence of lymph node metastasis, extent of gastric resection, and postoperative CA19-9 normalization on univariate analyses. Multivariate analysis revealed that pathological lymph node metastasis (p<0.001) and postoperative CA19-9 normalization were independent prognostic factors (p=0.001).

CONCLUSIONS

In patients with advanced gastric adenocarcinoma who underwent curative gastric resection, postoperative normalization of CA19-9 can be a surrogate for potentially curative surgical treatment and can be used as a good prognostic factor.

摘要

背景/目的:已知CA19-9与胃腺癌的浸润深度、淋巴结受累情况及腹膜转移呈正相关。在接受根治性胃切除术且术前CA19-9血清水平较高的患者中,我们评估了术后CA19-9恢复正常对预后的影响。

方法

在1439例行根治性胃切除术治疗进展期胃腺癌的患者中,回顾了102例术前血清CA19-9水平高于临界值(37 U/mL)的进展期胃腺癌患者的数据。如果术后6个月血清CA19-9水平降至37 U/mL以下,则认为CA19-9水平恢复正常。

结果

79例患者的CA19-9水平恢复正常,23例未恢复正常。单因素分析显示,根据浸润深度、淋巴结转移情况、胃切除范围及术后CA19-9是否恢复正常,预后存在统计学显著差异。多因素分析显示,病理淋巴结转移(p<0.001)和术后CA19-9恢复正常是独立的预后因素(p=0.001)。

结论

在接受根治性胃切除术的进展期胃腺癌患者中,术后CA19-9恢复正常可作为潜在根治性手术治疗的替代指标,并可作为良好的预后因素。

相似文献

1
Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer.术后CA19-9正常化对晚期胃癌患者的预后价值
Hepatogastroenterology. 2013 Mar-Apr;60(122):240-3. doi: 10.5754/hge12585.
2
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.术前血清中五种肿瘤标志物(癌胚抗原、CA19-9、甲胎蛋白、CA72-4和CA125)水平在胃癌中的预后价值
Hepatogastroenterology. 2014 May;61(131):863-9.
3
Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.胃中三分之一腺癌——临床病理特征预后意义的评估
Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.
4
The use of tumor markers as predictors of prognosis in gastric cancer.肿瘤标志物在胃癌预后预测中的应用。
Hepatogastroenterology. 2004 Sep-Oct;51(59):1544-7.
5
Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.多脏器切除术治疗局部进展期胃癌:一项意大利多中心观察性研究。
JAMA Surg. 2013 Apr;148(4):353-60. doi: 10.1001/2013.jamasurg.309.
6
Prognostic value of early postoperative tumor marker response in gastric cancer.胃癌患者术后早期肿瘤标志物反应的预后价值。
Ann Surg Oncol. 2013 Nov;20(12):3905-11. doi: 10.1245/s10434-013-3066-7. Epub 2013 Jun 27.
7
Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.术前血清CA 19-9水平检测不到与可切除胰腺腺癌患者生存率提高相关。
Ann Surg Oncol. 2004 Jul;11(7):644-9. doi: 10.1245/ASO.2004.11.025. Epub 2004 Jun 14.
8
Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.围手术期血清癌胚抗原水平可预测接受根治性胃切除术治疗的病理T2-4期胃癌患者的复发及生存情况。
Dig Surg. 2018;35(1):55-63. doi: 10.1159/000471931. Epub 2017 Apr 26.
9
Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer.使用敏感肿瘤标志物监测复发性胃癌患者的肿瘤动态,可获得更好的结果。
Anticancer Res. 2013 Apr;33(4):1621-7.
10
General and specific prognostic factors of early gastric carcinoma treated with curative surgery.根治性手术治疗早期胃癌的一般及特异性预后因素。
Hepatogastroenterology. 1999 May-Jun;46(27):1800-8.

引用本文的文献

1
Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection.结直肠癌根治术后脾密度与预后结局的相关性。
BMC Cancer. 2024 Apr 6;24(1):425. doi: 10.1186/s12885-024-12208-7.
2
CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report.起源于胸段食管中段贲门的产生CA19-9的食管腺癌:病例报告
Surg Case Rep. 2021 Jul 15;7(1):166. doi: 10.1186/s40792-021-01252-1.
3
Study on the Diagnosis of Gastric Cancer by Magnetic Beads Extraction and Mass Spectrometry.
磁珠提取与质谱联用诊断胃癌的研究
Biomed Res Int. 2020 Aug 5;2020:2743060. doi: 10.1155/2020/2743060. eCollection 2020.
4
Prognostic Significance of Platelet-Based Inflammatory Indicators in Patients with Gastric Cancer.血小板源性炎症指标在胃癌患者中的预后意义
World J Surg. 2018 Aug;42(8):2542-2550. doi: 10.1007/s00268-018-4527-8.
5
Peritoneal recurrence in gastric cancer following curative resection can be predicted by postoperative but not preoperative biomarkers: a single-institution study of 320 cases.胃癌根治性切除术后的腹膜复发可通过术后而非术前生物标志物进行预测:一项针对320例病例的单机构研究。
Oncotarget. 2017 May 8;8(44):78120-78132. doi: 10.18632/oncotarget.17696. eCollection 2017 Sep 29.
6
Carbohydrate Antigen 19-9-Positive Gastric Adenocarcinoma: Autopsy Findings and Review of the Literature.糖类抗原19-9阳性胃腺癌:尸检结果及文献综述
Case Rep Gastroenterol. 2017 Sep 26;11(3):545-553. doi: 10.1159/000479223. eCollection 2017 Sep-Dec.
7
Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer.术前血清巨噬细胞激活生物标志物可溶性甘露糖受体(sMR)和可溶性血红蛋白清除受体(sCD163),作为胃癌诊断和预后的新型标志物。
Oncol Lett. 2017 Sep;14(3):2982-2990. doi: 10.3892/ol.2017.6547. Epub 2017 Jul 8.
8
Influence of prognostic nutritional index and tumor markers on survival in gastric cancer surgery patients.预后营养指数和肿瘤标志物对胃癌手术患者生存的影响。
Langenbecks Arch Surg. 2017 May;402(3):501-507. doi: 10.1007/s00423-017-1572-y. Epub 2017 Mar 15.
9
An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4.一种基于血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原72-4(CA72-4)水平筛查胃癌的替代方法。
J Gastrointest Cancer. 2018 Mar;49(1):57-62. doi: 10.1007/s12029-016-9912-7.
10
Prognostic values of normal preoperative serum cancer markers for gastric cancer.胃癌术前血清肿瘤标志物正常的预后价值
Oncotarget. 2016 Sep 6;7(36):58459-58469. doi: 10.18632/oncotarget.11248.